The high comorbidity burden of the hepatitis C virus infected population in the United States.

ABSTRACT:

Background

Chronic hepatitis C (HCV) disease can be complicated with comorbid conditions that may impact treatment eligibility and outcomes. The aim of the study was to systematically review comorbidities and symptoms in an HCV infected population, specifically assessing comorbidities associated with HCV anti-viral treatment and disease, as well as comparing comorbidities between an HCV infected and uninfected control population.

Methods

This was a retrospective cohort study within a United States medical claims database among patients with chronic HCV designed to estimate the two-year period prevalence of comorbidities. Patients with two HCV diagnosis codes, 24 months of continuous health insurance coverage, and full medical and pharmacy benefits were included.

Results</

SUBMITTER: Louie KS 

PROVIDER: S-EPMC3342214 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature